首页>
外国专利>
METHOD FOR AMELIORATING LIVER FIBROSIS BY USING NANOPARTICLE CONTAINING TYROSINE KINASE INHIBITOR
METHOD FOR AMELIORATING LIVER FIBROSIS BY USING NANOPARTICLE CONTAINING TYROSINE KINASE INHIBITOR
展开▼
机译:含酪氨酸激酶抑制剂的纳米颗粒改善肝纤维化的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is related to a method for ameliorating liver fibrosis in a subject. The present invention utilizes copolymers of polyethylene glycol and poly (D, L-lactide-co-glycolide) to form nanoparticle composition containing tyrosine kinase inhibitor, such as Sorafenib. The use of nanoparticle composition is non-toxic and can increase the stability and decrease the release of drug in blood circulation. The pharmaceutical composition is in an injectable form. The nanoparticle composition containing tyrosine kinase inhibitor of the present invention can effectively ameliorate liver fibrosis including decreasing extracellular matrix accumulation, suppressing hepatic stellate cell activity, shrinking of abnormal blood vessel, and lowering microvascular density in fibrotic liver; hence is suitable for clinical application for the treatment of liver fibrosis.
展开▼